|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LETTER TO THE EDITOR
Predictions based on in vitro data. 1) Synaptic inhibition is a powerful mechanism that regulates degree and type of pacemaker bursting (4). In hypoxia, synaptic inhibition is decreased through shut down of inhibitory neurons, which facilitates bursting in some, but not all, pacemakers.
We predict that this is also the case in vivo. There will be hypoxic and normoxic conditions where changes in the activation of inhibitory neurons will alter the relative contribution of pacemakers and bursting properties. The deeply rooted belief that inhibition plays a role only in adult animals and only in vivo and in situ is pure speculation.
2) Neuromodulation is an equally powerful mechanism to regulate pacemaker properties (4, 5). Neuromodulators amplify and weaken bursting and turn pacemaker properties on and off. The nervous system is equipped with an impressive arsenal of noradrenergic, serotonergic, and peptidergic inputs projecting from numerous brain regions onto pacemaker neurons.
We predict that these projections also play roles under in vivo conditions. For example, noradrenergic descending inputs from the pons could endogenously activate
1-receptors, which in vitro produce an augmenting burst shape characteristic for eupnea. The belief that pons suppresses pacemaker activity is pure speculation.
Last words. In vitro research has demonstrated that bursting produced by pacemakers is not a rigid cellular property incompatible with the high degree of regulation necessary to generate a complex behavior such as eupnea. Multiple synaptic and modulatory processes prevent pacemakers from being simple "autorhythmic" cells when embedded in a network (4). Instead, bursting of pacemakers is a highly plastic nonlinear property that is useful in synchronizing, escaping inhibitory processes, amplifying excitatory processes, influencing timing, and stabilizing or destabilizing network activity (4).
We hope that some day our data will be able to eradicate the deeply rooted and undocumented belief that pacemakers are simple phylogenetic backup mechanisms useful only under emergency situations such as gasping. Overly simplistic statements, such as "pacemakers are suppressed during eupnea" are not based on evidence and only hamper progress in unraveling the roles of pacemakers in the respiratory network.
FOOTNOTES
Address for reprint requests and other correspondence: J.-M. Ramirez, Dept. of Organismal Biology and Anatomy, Committee on Neurobiology, The Univ. of Chicago, Chicago, IL 60637 (e-mail: jramire{at}uchicago.edu)
REFERENCES
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |